In total, 16 of 376 BRCA1 and 26 of 447 BRCA2 mutation carriers were diagnosed with PCa during median follow-up of 5.9 and 5.3 yr, respectively (Table 1). The gene discussed is BRCA1; the disease is posterior cortical atrophy.